ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients

ClinicalTrials.gov ID: NCT06608641

Public ClinicalTrials.gov record NCT06608641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Oral, Multiple-dose, Parallel, Randomized Study to Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients With Acute Mania Episodes With or Without Mixed Features

Study identification

NCT ID
NCT06608641
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jina Pharmaceuticals Inc.
Industry
Enrollment
490 participants

Conditions and interventions

Interventions

  • Endoxifen enteric-coated tablet (8 mg) Drug
  • Placebo Tablets Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 18, 2024
Primary completion
May 31, 2025
Completion
Nov 30, 2025
Last update posted
Mar 16, 2025

2024 – 2025

United States locations

U.S. sites
12
U.S. states
4
U.S. cities
11
Facility City State ZIP Site status
Synexus Cerritos California 90703
NRC Research Institute Los Angeles California 90015
NRC Research Institute Orange California 92868
Medical Research of Westchester, Inc. Miami Florida 33165
Sunshine Medical Research Studies Inc. Miami Florida 33186
Innovative Clinical Research, Inc. Miami Lakes Florida 33016
South Florida Research Phase I-IV, Inc. Miami Springs Florida 33166
Santos Research Center, CORP Tampa Florida 33615
Accelerated Clinical Trials, LLC East Point Georgia 30344
Accelerated Clinical Trials, LLC Norcross Georgia 30092
Accelerated Clinical Trials, LLC Peachtree Corners Georgia 30071
Precise Research Centers Flowood Mississippi 39232

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06608641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2025 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06608641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →